Focused Radiosurgery Extends Survival for Small Cell Lung Cancer Patients with Brain Metastases
3 Articles
3 Articles
Focused radiosurgery extends survival for small cell lung cancer patients with brain metastases
Patients with small cell lung cancer (SCLC) that had spread to the brain lived a median of 17 months after focused stereotactic radiosurgery, compared with nine months after an advanced form of whole brain radiation therapy, an unexpected secondary finding from the first randomized phase 3 trial to compare the treatment approaches in this population.
Radiosurgery linked to longer survival for small cell lung cancer with brain metastases
Patients with small cell lung cancer (SCLC) that had spread to the brain lived a median of 17 months after focused stereotactic radiosurgery, compared with nine months after an advanced form of whole-brain radiation therapy, an unexpected secondary finding from the first randomized Phase III trial to compare the treatment approaches in this population.
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium









